Companies / Israel
SciGen Continues To Expand Abroad
June 2006 | FDI AlertSingapore-based pharmaceutical company SciGen is planning to build a US$30mn R&D facility in Israel, which will also manufacture biotech products utilising knowledge acquired from Israeli drugmaker Savient Pharmaceuticals. The plant will be located in Rehovot, south of Tel Aviv, close to the Weizmann Institute of Sciences, so that the company can benefit from the influence of skilled personnel in the area. Israel has been keen to attract funding into its life sciences industry and in 2005 34% of all foreign venture capital was invested in this area, totalling some
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
